MALIGNANT MESOTHELIOMA
Clinical trials for MALIGNANT MESOTHELIOMA explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT MESOTHELIOMA trials appear
Sign up with your email to follow new studies for MALIGNANT MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat mesothelioma
Disease control Recruiting nowThis study is testing whether the drug brentuximab vedotin can help control advanced malignant mesothelioma that has a specific marker called CD30 and cannot be removed by surgery. About 55 patients who have already tried other treatments will receive the drug through an IV every…
Matched conditions: MALIGNANT MESOTHELIOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New hope for tough cancers: first test of experimental drug begins
Disease control Recruiting nowThis is the first time a new drug called ISM6331 is being tested in people. The main goal is to find a safe dose and understand its side effects in 100 adults with advanced cancers like mesothelioma or other solid tumors that have not responded to standard treatments. Researchers…
Matched conditions: MALIGNANT MESOTHELIOMA
Phase: PHASE1 • Sponsor: InSilico Medicine Hong Kong Limited • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Doctors reprogram Patients' own cells to attack advanced lung cancer
Disease control Recruiting nowThis early-stage study is testing the safety of a new personalized immunotherapy for people with advanced cancer that has spread to the lining of the lungs (pleura). Doctors take immune cells from a patient's own lung fluid, grow large numbers of them in a lab, and then infuse th…
Matched conditions: MALIGNANT MESOTHELIOMA
Phase: PHASE1 • Sponsor: David Bartlett, MD • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC